Nusinersen Sodium API Suppliers & Bulk Manufacturers
Available Forms: API (drug substance)
Available Strengths: Supplied to an in-house or pharmacopoeial specification
Reference Brands: Spinraza
Category: Active Pharmaceutical Ingredient
Nusinersen is an antisense oligonucleotide supplied as its sodium salt for intrathecal products. It is sourced by oligonucleotide formulators, CDMOs and R&D teams.
Manufacture or export Nusinersen Sodium API? List it or send an offer →
Product Description:
Nusinersen is an antisense oligonucleotide that binds to SMN2 pre-messenger RNA and changes how it is spliced, so that cells make more full-length survival motor neuron (SMN) protein. It is approved for the treatment of spinal muscular atrophy in children and adults, and in the EU specifically for 5q spinal muscular atrophy (reference brand: Spinraza).
Specification at a glance
| Traded form | Heptadecasodium salt of an 18-mer, fully 2'-O-(2-methoxyethyl) modified phosphorothioate oligonucleotide made by solid-phase synthesis |
|---|---|
| CAS number | 1258984-36-9 |
| Molecular formula | C234H323N61O128P17S17 (free acid); supplied as the heptadecasodium salt |
| Molecular weight | 7501.0 g/mol (heptadecasodium salt) |
| Pharmacopoeia | No pharmacopoeia monograph found; supplied to an in-house specification. |
Regulatory files and timing
The FDA list of Drug Master Files (third quarter 2026) shows 9 active Type II API DMFs for this molecule. Few filings usually means few qualified sources, so early contact with suppliers pays off. For Europe, ask whether the supplier holds a CEP or an EU ASMF and, for imports into the EU, a written confirmation.
Generic or biosimilar entry. United States: Patent expiry; entry not confirmed (Dec 2030 (compound patent)). European Union: No confirmed date.
Handling and quality points
Nusinersen is made by solid-phase phosphoramidite synthesis and chromatographic purification, so the impurity profile is dominated by closely related oligonucleotides: shorter and longer sequences, and species where a phosphorothioate has become a phosphodiester. Each phosphorothioate linkage is a stereocentre, so the product is a diastereomer mixture and the supplier's process should give a consistent profile. As the finished product is given intrathecally, endotoxin and bioburden limits are tight, and the hygroscopic powder needs moisture-protected packing and controlled storage.
Send an API enquiry All specialty APIs
Brand names are trademarks of their respective owners and identify the reference medicine only. Information is general and was checked in October 2026; confirm specifications and filings with the supplier before purchase.
Nusinersen Sodium API — third party manufacturing & bulk supply
Nusinersen Sodium API is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Nusinersen Sodium API is supplied as API (drug substance) — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Nusinersen Sodium API listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Nusinersen Sodium API →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
Typical requests are the GMP certificate, a US DMF letter of access or EU ASMF where filed, a CoA covering purity by ion-pair or anion-exchange HPLC, mass spectrometry identity, sodium and water content, and endotoxin. Buyers also ask for stability data and a summary of how the sequence and backbone chemistry are confirmed. A nitrosamine and residual solvent assessment is increasingly part of the package.
Not directly. ICH Q3A and Q3B exclude oligonucleotides, so impurity limits are set case by case using the reference product profile and regulatory precedent. Ask the supplier how they identify and qualify the n-1, n+1 and phosphodiester impurities and how their limits compare with the reference product.
Yes. PharmaTradz connects licensed manufacturers, CDMOs and R&D teams with GMP-compliant oligonucleotide makers able to supply nusinersen sodium. We review their documents before introducing you, and your identity stays private until both sides are ready to talk.
Related Products
Trabectedin API
Strength:
USP grade or in-house specification
Form: API (drug substance)
Reference Brands: Yondelis
View DetailsPonatinib Hydrochloride API
Strength:
USP grade or in-house specification
Form: API (drug substance)
Reference Brands: Iclusig
View DetailsFerric Derisomaltose API
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: API (drug substance)
Reference Brands: Monoferric, Monofer
View DetailsLinaclotide API
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: API (drug substance)
Reference Brands: Linzess, Constella
View DetailsAmyl Nitrite
Strength:
Purity 99%
Form: Clear, yellowish volatile liquid with fruity odor
Reference Brands:
View DetailsGadobenic Acid
Strength:
Supplied as high-purity API powder
Form: White to off-white crystalline powder
Reference Brands: MultiHance (US/EU)
View DetailsEfinaconazole
Strength:
Standard commercial purity ranges 98% (HPLC)
Form: White to beige crystalline powder
Reference Brands: Jublia (US)
View DetailsAmiodarone
Strength:
Assay 98.5–101.0% (USP/EP Standard )
Form: fine white powder
Reference Brands: Cordarone (US/EU)
View DetailsUsually answered within 48 hours | GMP documents shared before you commit